PhotoPharmics (American Fork, UT) advances commercialization of Celeste®, its FDA Breakthrough-designated Parkinson’s device, by forming a Commercial Advisory Board, adding executive talent, and surpassing clinical milestones, strengthening Utah’s medtech leadership on a global stage.
by Mark Tullis
Nucleus Fund invests in Provo's Terraphene, a hemp-based materials startup with a nine-figure pallet supply deal, fire- and strength-tested building materials, and a pitch to help refill the Great Salt Lake by replacing thirsty alfalfa acreage with hemp.
DHS named Fortem Technologies (Lindon, UT) the only small business among seven prime contractors on a five-year, $1B+ counter-drone IDIQ. CEO Jon Gruen discusses the win, subcontractors Lockheed Martin and Microsoft, and plans to scale Utah manufacturing.
South Jordan-based Obra emerges from stealth with two linked products, Obra Jobs and Obra Hire, betting that AI broke hiring's inbound signal and that a trust-first, outbound-focused platform can restore it.